Practice parameters for hemodynamic support of sepsis in adult patients: 2004 update

被引:323
作者
Hollenberg, SM
Ahrens, TS
Annane, D
Astiz, ME
Chalfin, DB
Dasta, JF
Heard, SO
Martin, C
Napolitano, LM
Susla, GM
Totaro, R
Vincent, JL
Zanotti-Cavazzoni, S
机构
关键词
sepsis; hemodynamic support; fluid resuscitation; vasopressor therapy; inotropic therapy;
D O I
10.1097/01.CCM.0000139761.05492.D6
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objective. To provide the American College of Critical Care Medicine with updated guidelines for hemodynamic support of adult patients with sepsis. Data Source., Publications relevant to hemodynamic support of septic patients were obtained from the medical literature, supplemented by the expertise and experience of members of an international task force convened from the membership of the Society of Critical Care Medicine. Study Selection. Both human studies and relevant animal studies were considered. Data Synthesis: The experts articles reviewed the literature and classified the strength of evidence of human studies according to study design and scientific value. Recommendations were drafted and graded levels based on an evidence-based rating system described in the text. The recommendations were de-bated, and the task force chairman modified the document until <10% of the experts disagreed with the recommendations. 4Conclusions. An organized approach to the hemodynamic support of sepsis was formulated. The fundamental principle is that clinicians using hemodynamic therapies should define specific goals and end points, titrate therapies to those end points, and evaluate the results of their interventions on an ongoing basis by monitoring a combination of variables of global and regional perfusion. Using this approach, specific recommendations for fluid resuscitation, vasopressor therapy, and inotropic therapy of septic in adult patients were promulgated.
引用
收藏
页码:1928 / 1948
页数:21
相关论文
共 230 条
[1]  
ABBOUD FM, 1990, BLOOD VESSELS, V27, P106
[2]  
Annane D, 1998, BRIT J CLIN PHARMACO, V46, P589
[3]   Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock [J].
Annane, D ;
Sébille, V ;
Charpentier, C ;
Bollaert, PE ;
François, B ;
Korach, JM ;
Capellier, G ;
Cohen, Y ;
Azoulay, E ;
Troché, G ;
Chaumet-Riffaut, P ;
Bellissant, E .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (07) :862-871
[4]   EVALUATION OF FLUID THERAPY IN ADULT RESPIRATORY-FAILURE [J].
APPEL, PL ;
SHOEMAKER, WC .
CRITICAL CARE MEDICINE, 1981, 9 (12) :862-869
[5]  
ASTIZ M, 1988, CIRC SHOCK, V26, P311
[6]   BLOOD LACTATE LEVELS ARE SUPERIOR TO OXYGEN-DERIVED VARIABLES IN PREDICTING OUTCOME IN HUMAN SEPTIC SHOCK [J].
BAKKER, J ;
COFFERNILS, M ;
LEON, M ;
GRIS, P ;
VINCENT, JL .
CHEST, 1991, 99 (04) :956-962
[7]  
BARBER AE, 1993, J IMMUNOL, V150, P1999
[8]  
BARRY K, 1967, NEW ENGL J MED, V270, P1371
[9]   Hemodynamic effects of IV milrinone lactate in pediatric patients with septic shock - A prospective, double-blinded, randomized, placebo-controlled, interventional study [J].
Barton, P ;
Garcia, J ;
Kouatli, A ;
Kitchen, L ;
Zorka, A ;
Lindsay, C ;
Lawless, S ;
Giroir, B .
CHEST, 1996, 109 (05) :1302-1312
[10]  
BAUM TD, 1990, CIRC SHOCK, V30, P385